Qin Wang, PhD
Professor of Neuroscience & Regenerative Medicine | Augusta University
Augusta, GA, UNITED STATES
Qin Wang researches the neuropharmacology and signaling mechanisms underlying neurological and psychiatric disorders.
Multimedia
Publications:
Documents:
Videos:
Audio/Podcasts:
Biography
My research interests focus on understanding the neuropharmacology and signaling mechanisms underlying neurological and psychiatric disorders. Using combined molecular, genetic, cell biological, biochemical, pharmacological and behavioral approaches, as well as animal models and human samples, my lab research tackles how cell surface receptor signaling regulates normal brain functions and contributes to disease pathogenesis. Throughout my research, I have always tried to tie our molecular and cellular studies into the context of brain physiology and disease pathology with a goal to translate our bench work into novel clinical applications.
Areas of Expertise (5)
Neurological Disorders
Regenerative Medicine
Molecular Neuropharmacology
Neuroscience
Neuropharmacology
Accomplishments (2)
Nominated for Jarman F. Lowder Endowed Professor of Neuroscience, UAB SOM
2021
UAB SOM AMC21 Featured Discovery
2020
Education (2)
University of Iowa: Ph.D., Molecular Biology 1999
Peking University Health Science Center (Bejing Medical University): M.D. 1992
Affiliations (6)
- Sigma Xi Honor Society : Member
- American Society for Pharmacology and Experimental Therapeutics : Member
- American Society for Biochemistry and Molecular Biology : Member
- Alzheimer’s Association : Member
- Society for Neuroscience : Member
- American Heart Association : Member
Links (1)
Media Appearances (8)
Augusta University receives ‘high research activity’ ranking from Carnegie Classification
JAGWire online
2022-02-01
Just in the past month, Augusta University has already made several exciting announcements regarding research, including that renowned immunologists and vascular biologists Drs. Klaus Ley and Catherine “Lynn” Hedrick from California’s La Jolla Institute for Immunology have been named co-directors of the new Center for Immunology at MCG. In addition, Dr. Qin Wang, an expert in molecular neuropharmacology, has recently been named the inaugural director of the Program for Alzheimer’s Therapeutics Discovery. Also, Dr. Yanbin Dong, a molecular geneticist and cardiologist at MCG, has been named director of the Georgia Prevention Institute.
Dr. Qin Wang will lead new Program for Alzheimer’s Therapeutics Discovery at MCG
JAGWire online
2022-01-24
Dr. Qin Wang, an expert in molecular neuropharmacology and signaling research exploring how cell surface receptor signaling regulates healthy brain function and contributes to neurological and psychiatric disorders, has been named the inaugural director of the Program for Alzheimer’s Therapeutics Discovery at the Medical College of Georgia.
Medical College of Georgia growing in students, statewide reach, now adding star recruits
The Augusta Chroncle online
2022-01-22
Drs. Hedrick and Ley will be Georgia Research Alliance Eminent Scholars and will be joined by a third new GRA Eminent Scholar, Dr. Qin Wang from UAB, who researches therapeutics for Alzheimer's disease.
Georgia Research Alliance names three new Augusta University eminent scholars
SaportaReport online
2022-01-21
The third eminent scholar announced this week is Dr. Qin Wang, an expert in molecular neuropharmacology exploring how cell surface receptor signaling regulates healthy brain function and contributes to neurological and psychiatric disorders. She has been named the inaugural director of the Program for Alzheimer’s Therapeutics Discovery at the Medical College of Georgia.
I-TEAM: Augusta University doctor makes breakthrough in Alzheimer’s research
WRDW tv
2022-05-26
An all-new I-TEAM investigation has uncovered an alarming trend with Alzheimer’s disease. Experts predict a significant spike in cases in just the next few years, but it’s not all bad news. Our Meredith Anderson found a new doctor at Augusta University who has made a new breakthrough. By 2025, the Alzheimer’s Association believes cases in Georgia and South Carolina will jump by more than a fourth. Currently, Georgia is 26.7% ‚and S.C. is 26.3%.
Peptide delivered by nasal spray can reduce seizure activity, protect neurons in Alzheimer’s, epilepsy
Eureka Alert online
2022-08-15
A novel peptide augments the brain’s natural mechanism to help prevent seizures and protect neurons in research models of both Alzheimer’s and epilepsy, scientists report. The A1R-CT peptide the scientists developed, which can be administered through a nasal spray, holds promise for tamping down the uncontrolled electrical activity that is common after traumatic brain injury, stroke and which affects more than half of individuals with Alzheimer’s, says Dr. Qin Wang, neuropharmacologist and founding director of the Program for Alzheimer’s Therapeutics Discovery at the Medical College of Georgia at Augusta University.
Study shows nasal spray helps slow down Alzheimer’s progression by taming seizures
WJBF tv
2022-08-24
Patients suffering from seizures due to Alzheimer’s could soon get some relief with the help of a nasal spray. “Hopefully we all can contribute to the final cure for this disease,” said Dr. Qin Wang, a Neuropharmacologist at the Medical College of Georgia. It’s not a cure but a breakthrough in Alzheimer’s research. Scientists at Medical College of Georgia developed a peptide delivered by nasal spray to reduce seizures common in early stage Alzheimer’s.
Researchers investigate novel treatment approach to Alzheimers
WPLG tv
2022-10-11
It’s estimated that 5.8 million Americans have Alzheimer’s disease or some form of dementia. Getting medication to the affected area in the brain to provide treatment before the disease takes hold is the challenge. For a decade now, Dr. Quin Wang and her team at the Medical College of Georgia in Augusta have been working with a peptide derived from a surface receptor in the brain.